Monday, June 4, 2007
Welcome
Susan Bartlett Foote, Director, MTLF, Associate Professor, School of Public Health, University of Minnesota
Senator Dave Durenberger, Chair MTLF Advisory Board; Chair, National Institute of Health Policy
Robert M. Nerem, PhD, Director of the Institute for Bioengineering & Bioscience
Keynote Harlan Weismann, MD, Chief Science and Technology Officer for Medical Devices and Diagnostics, Johnson & Johnson "The Convergence from a Scientific and Clinical Perspective"
Tuesday, June 5, 2007
Keynote Richard Kuntz, MD, Senior Vice President & President, Medtronic Neurological, Gastroenterology & Urology, and Obesity Management
Session I: Case Studies of Combination Products Now on the Market
Moderator: Robert Nerem, PhD
Speakers: Geoff Mackay, President and CEO, Organogenesis Gail Naughton, PhD, Dean, College of Business Administration, San Diego State University John McPherson, PhD, Senior Vice President, Head Biological Products R&D, Genzyme 10:30 a.m.
Download Presentations (PDF)
Session II: Regulatory & Reimbursement Issues
Moderator: Senator David Durenberger, Chair, MTLF Advisory Board; Chair, National Institute of Health Policy
Speakers: Celia Witten, PhD, MD, Director, Office of Cellular, Tissue and Gene Therapy for Biologics, Food and Drug Administration Dan Schultz, MD Director, Center for Devices and Radiological Health, Food and Drug Administration
Download Presentations (PDF)
Session III: Scientific, Developmental & Business Strategies for Converging Biologics with Devices
Moderator: Jonathan Gertler, MD, Manager, Director Investment Banking, Cowen and Company
Panel Members: George Dunbar, MBA, President & CEO, Aastrom Biosciences, Inc. Deborah Kilpatrick, Vice President of Marketing Development, CardioDx Inc. Seth Rudnick, MD, Partner, Canaan Partners Harry Glorikian, MBA, Managing Partner and Management Consultant of Scientific Advisors
Download Presentations (PDF)
General Discussion – Business Models for the Medical Device Industry of the Future
